The government recently selected The Bio-Health Industry as the “Three major new industries” and plans to expand its support for the Big Data R&D sector from 2.6 trillion won annually to over 4 trillion won by 2025. This shows the importance of the Big Data in the bio and medical industries. This is why NKCL, which is planning to build a medical big data trading platform by combining the bio industry and blockchain, attracts attention.

 NKCL is a blockchain development and platform distributor based on a research institute that has been developing and researching NK immunocyte for 11 years. NK cells are immune cells that are being spotlighted as anti-cancer drugs of next-generation which detects the abnormal cells including cancer cells in our body and instantly destroys them. NKCL provides personalized immune-care therapy using the method of extracting NK cells from the patient’s own blood, culturing them outside of the body, and then injecting them into the patient’s body.

 NKCL records the medical data such as clinical results, culture conditions and results of NK cell procedures that occur during this treatment in blockchain, and allows access from anywhere in the world through simple authentication. It is designed to enable NKCL procedures and concierge services regardless of location. Due to the characteristics of the blockchain, falsification is prevented and data source tracking is possible to ensure stability and reliability of records.

 Particularly, NKCL plans to manage and operate medical data more safely and quickly by recording it on a private blockchain that allows only those who have been certified to participate in the server, rather than a public blockchain that allows anyone to access the medical data.

 The NKCL will also expand its recorded medical data to a “medical big data trading platform.” Customers can receive financial compensation by providing their own medical data, and medical providers such as medical institutions and pharmaceutical companies produce virtuous cycles that contribute to medical development such as patient custom care and R&D through the corresponding medical data.

 Meanwhile, NKCL is expected to use NKCL tokens, which will be issued on public blockchain, as payment method for NKCL platform (hospital, anti-cancer center,

beauty clinic, anti-aging center, NK cell-related product online and offline shopping mall) that is scheduled to be opened later. "By linking NK cells to blockchain,

which are now being spotlighted as next-generation anti-cancer treatment, we launched them for the convenience and safer services of patients and customers,"

and NKCL official said, "NKCL will be a new paradigm for medical platforms.”